- Home
- TLSI vs BWAY Comparison
TLSI vs BWAY Comparison
Compare TLSI & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- BWAY
- Stock Information
- Founded
- TLSI 2010
- BWAY 2003
- Country
- TLSI United States
- BWAY Israel
- Employees
- TLSI N/A
- BWAY N/A
- Industry
- TLSI Medical Specialities
- BWAY Medical/Dental Instruments
- Sector
- TLSI Health Care
- BWAY Health Care
- Exchange
- TLSI Nasdaq
- BWAY Nasdaq
- Market Cap
- TLSI 244.3M
- BWAY 280.7M
- IPO Year
- TLSI N/A
- BWAY 2019
- Fundamental
- Price
- TLSI $4.70
- BWAY $16.75
- Analyst Decision
- TLSI Strong Buy
- BWAY Strong Buy
- Analyst Count
- TLSI 4
- BWAY 2
- Target Price
- TLSI $11.13
- BWAY $18.00
- AVG Volume (30 Days)
- TLSI 131.5K
- BWAY 61.5K
- Earning Date
- TLSI 11-13-2025
- BWAY 11-11-2025
- Dividend Yield
- TLSI N/A
- BWAY N/A
- EPS Growth
- TLSI N/A
- BWAY 679.98
- EPS
- TLSI N/A
- BWAY 0.11
- Revenue
- TLSI $35,990,000.00
- BWAY $46,084,000.00
- Revenue This Year
- TLSI $56.71
- BWAY $335.63
- Revenue Next Year
- TLSI $52.25
- BWAY $22.10
- P/E Ratio
- TLSI N/A
- BWAY $60.12
- Revenue Growth
- TLSI 45.50
- BWAY 26.50
- 52 Week Low
- TLSI $3.42
- BWAY $7.84
- 52 Week High
- TLSI $5.88
- BWAY $17.49
- Technical
- Relative Strength Index (RSI)
- TLSI 45.51
- BWAY 62.33
- Support Level
- TLSI $4.87
- BWAY $16.44
- Resistance Level
- TLSI $5.18
- BWAY $17.49
- Average True Range (ATR)
- TLSI 0.23
- BWAY 0.68
- MACD
- TLSI -0.01
- BWAY 0.08
- Stochastic Oscillator
- TLSI 44.74
- BWAY 74.83
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.